(VIANEWS) – For those who hold NeuroMetrix stock (NASDAQ:NURO), today is quite a surprise. The biotech company, which saw massive gains yesterday, made huge announcements. Today, these gains continue to be recurrent.

The NeuroMetrix camp is quiet today but the stock continues to see gains that are equal to yesterday’s announcement. So what’s the story? Retail traders seem to be taking NURO stock, and then running with it.

NeuroMetrix had dropped big news for investors, as InvestorPlace’s William White reported. Quell, a neurostimulation system that aids fibromyalgia sufferers in managing their symptoms easily, is now available. Investors flocking to NURO stock were able to see a gain of more than 140% after the news.

Shares of NeuroMetrix (NURO) rose by a staggering 56.73% to $32.60 at 09:43 EST on Thursday, after two successive sessions in a row of gains. NASDAQ Composite is rising 0.92% to $14,631.95, after two sequential sessions in a row of gains. This seems, so far, a somewhat positive trend exchanging session today.

NeuroMetrix’s last close was $10.04, 74.04% under its 52-week high of $38.67.


Today’s last reported volume for NeuroMetrix is 16290997 which is 172.12% above its average volume of 5986669.

NeuroMetrix’s Revenue

Year-on-year quarterly revenue growth declined by 0.8%, now sitting on 7.36M for the twelve trailing months.


NeuroMetrix’s last week, last month’s, and last quarter’s current volatility was a positive 0.31%, a negative 0.25%, and a positive 2.52%, respectively.

NeuroMetrix’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.62% (last week), 2.38% (last month), and 2.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NeuroMetrix’s stock is considered to be oversold (<=20).

NeuroMetrix’s Stock Yearly Top and Bottom Value

NeuroMetrix’s stock is valued at $32.60 at 09:43 EST, way under its 52-week high of $38.67 and way above its 52-week low of $1.39.

NeuroMetrix’s Moving Average

NeuroMetrix’s worth is way above its 50-day moving average of $3.59 and way higher than its 200-day moving average of $3.53.

Previous days news about NeuroMetrix (NURO)

Neurometrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boost. According to MarketWatch on Tuesday, 20 July, “Shares of NeuroMetrix Inc. rocketed 241% toward a two-year high on record volume, after the Massachusetts-based medical device company said its Quell transcutaneous electric nerve stimulator received “Breakthrough Designation” from the Food and Drug Administration to treat fibromyalgia symptoms in adults. ”

NURO stock: why reddit traders are targeting red-hot neurometrix today. According to InvestorPlace on Wednesday, 21 July, “Things are quiet out of the NeuroMetrix camp today, and yet, the stock is seeing gains equal to those resulting from yesterday’s announcement. “, “AsInvestorPlace’s William White reported yesterday, NeuroMetrix dropped some very big news on investors. ”

More news about NeuroMetrix (NURO).


Please enter your comment!
Please enter your name here